Neal Ready

7PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 09, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial.

Andrew J Armstrong, Hilary Dietz, David Balli

|Apr 02, 2025
Tumor-Associated Molecules Lead the Way to New Therapies for Small Cell Lung Cancer.

Cameron Oswalt, Neal Ready

|Feb 04, 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.

Cameron Wood, Liliana Lyniv, James M Isaacs

|Sep 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.

Daniel Morgensztern, Neal Ready, Melissa L Johnson

Pageof 2